KS
Export
Kaposi's sarcoma-derived cell line
Cell Type:
Lymphatic Endo.
Tissue Origin:
capillary
Species:
human
Research Area:
Cancer Research/Cell Biology
Cell Characteristics:
Suspension
Transfection Information
Lonza Optimized Protocol
Optimization Guideline
Filter:
Any Substrate
Any Platform
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
optimization strategy
to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol
Kit
Program
Cells
Efficiency
Viable Cells
Substrate
Format
Platform
V
A-023
1e6
37%
95%
Plasmid (general)
µg
100 µl
I/II/2b
V
G-016
1e6
40%
95%
Plasmid (general)
µg
100 µl
I/II/2b
V
T-027
1e6
52%
70%
Plasmid (general)
µg
100 µl
I/II/2b
Citations
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Categories:
Transfection
Authors:
Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, Rovira II, Nguyen AT, Malide D, Combs CA, Hall G, Zhang J, Raffeld M, Rogers TB, Stetler-Stevenson W, Frank JA, Reitz M, Finkel T
In:
J Exp Med (2006) 203(5): 1235-1247